Sign In
Buy DXCM
$72.77
-0.680 (-0.93%)
At Close: Jun 03, 2026
Countdown to DexCom (DXCM) Q4 Earnings: A Look at Estimates Beyond Revenue and EPS
10:21am, Monday, 10'th Feb 2025
Evaluate the expected performance of DexCom (DXCM) for the quarter ended December 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics
Should You Buy DexCom Stock Before Feb. 13?
09:30am, Thursday, 06'th Feb 2025
DexCom (DXCM 1.51%) is a healthcare company that makes continuous glucose monitoring (CGM) devices, which help people track glucose levels.
Prediction: This Top Growth Stock Will Outperform the Market in the Next Decade
09:15am, Monday, 03'rd Feb 2025
Medical device specialist DexCom (DXCM -0.90%) has substantially underperformed the market over the trailing-12-month period. The diabetes-focused company disappointed investors last year due to unimp
Got $2,000? 2 Top Growth Stocks to Buy and Hold for Years
08:45am, Monday, 03'rd Feb 2025
The bull market of the past year or more has reinvigorated investors' interest across a range of industries, and the performance of many top stocks reflects this reality. However, a share price moving
SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its fourth quarter and fiscal year 2024 financial results after market close on Thursday, February 13, 2
DXCM's Preliminary Results Show Strong Growth: How to Play the Stock?
11:50am, Tuesday, 21'st Jan 2025
DexCom Inc. DXCM is off to a strong start in 2025, with its stock rallying 5.7% following the release of its preliminary results for the fourth quarter and fiscal 2024 on Jan. 13, 2025. The company'
DexCom: Fairly Priced In 2025; Why I'm Not Expecting A Share Price Comeback
04:43pm, Friday, 17'th Jan 2025
DexCom, Inc.'s growth is impressive but limited by its niche market, with my projected ceiling being ~$7.5bn in peak annual revenues. Despite positive Q4 2024 results, DexCom's stock is fairly valued,
2 Healthcare Stocks to Buy Hand Over Fist in January
05:22am, Thursday, 16'th Jan 2025
Stocks tend to perform well in January, but that's not a good reason to invest this month. Strong returns aren't made in a single 30-day period.
DexCom Stock Up Following Strong Preliminary Q4 Results & 2025 Outlook
09:16am, Tuesday, 14'th Jan 2025
DXCM's top line reflects strong demand for its CGM sensors. International expansion is also driving sales higher.
Here's Why You Should Retain DexCom Stock in Your Portfolio for Now
09:26am, Monday, 13'th Jan 2025
DXCM continues to raise optimism among investors owing to its strong product portfolio.
Dexcom forecasts 2025 revenue mostly in-line with expectations
07:43am, Monday, 13'th Jan 2025
Dexcom forecast total annual revenue in line with Wall Street expectations on Monday, on bets of strong demand for its continuous glucose monitors for diabetes patients.
Dexcom Reports Preliminary, Unaudited Results for the Fourth Quarter and Fiscal Year 2024 and Initial 2025 Outlook
07:30am, Monday, 13'th Jan 2025
SAN DIEGO--(BUSINESS WIRE)--Dexcom Reports Preliminary, Unaudited Results for the Fourth Quarter and Fiscal Year 2024 and Initial 2025 Outlook.
3 Beaten-Down Stocks That May Be Due for Big Comebacks in 2025
08:30am, Wednesday, 08'th Jan 2025
The past year was a great one for the stock market as a whole, but there were plenty of companies that didn't do well in 2024. Shares of Celsius Holdings (CELH 0.93%), DexCom (DXCM -0.66%), and Nike (
These Were the 5 Worst-Performing Stocks in the Nasdaq-100 in 2024
07:45am, Saturday, 04'th Jan 2025
Now that we've shut the door on 2024, it's useful to look back at some of the best -- and, on the flip side, some of the worst -- performers of the year on the stock market. Many outliers were in the
Abbott and DexCom settle glucose monitor patent disputes
04:17pm, Monday, 23'rd Dec 2024
Abbott Laboratories said on Monday it and DexCom have reached an agreement to settle all patent disputes between the companies related to continuous glucose monitoring devices.
